Amgen Inc's Suppliers recorded an increase in sales by 8.63 % year on year in Q3 2026, sequentially sales grew by 32.02 %, Amgen Inc's cost of sales deteriorated by -9.54 % year on year, relative to one quarter ago cost of sales fell by -0.82 % in Q3.
Amgen Inc's Suppliers recorded an increase in sales by 8.63 % year on year in Q3 2026, sequentially sales grew by 32.02 %, Amgen Inc's cost of sales deteriorated by -9.54 % year on year, compare to one quarter ago cost of sales fell by -0.82 % in Q3.
Certain raw materials, medical devices and components necessary for the commercial
and/or clinical manufacturing of our products are provided by and are the proprietary
products of unaffiliated third-party suppliers, certain of which may be our
only sources for such materials. We currently attempt to manage the risk associated
with such suppliers by inventory management, relationship management and evaluation
of alternative sources when feasible. We also monitor the financial condition
of certain suppliers and their ability to supply our needs.
We rely on third-party suppliers for certain of our raw materials, medical
devices and components.
We perform various procedures to assist in authenticating the source of raw
materials, including intermediary materials used in the manufacture of our products,
which include verification of the country of origin. These procedures are incorporated
into the manufacturing processes we and our third-party contract manufacturers
perform.
Amgen Inc's Comment on Supply Chain
Certain raw materials, medical devices and components necessary for the commercial
and/or clinical manufacturing of our products are provided by and are the proprietary
products of unaffiliated third-party suppliers, certain of which may be our
only sources for such materials. We currently attempt to manage the risk associated
with such suppliers by inventory management, relationship management and evaluation
of alternative sources when feasible. We also monitor the financial condition
of certain suppliers and their ability to supply our needs.
We rely on third-party suppliers for certain of our raw materials, medical
devices and components.
We perform various procedures to assist in authenticating the source of raw
materials, including intermediary materials used in the manufacture of our products,
which include verification of the country of origin. These procedures are incorporated
into the manufacturing processes we and our third-party contract manufacturers
perform.
AMGN's Suppliers Net profit fell by
AMGN's Suppliers Net margin fell in Q3 to
-8.61 %
7.65 %
AMGN's Suppliers Net profit fell by -8.61 %
AMGN's Suppliers Net margin fell in Q3 to 7.65 %
Amgen Inc's Suppliers Sales Growth
in Q3 2026 by Industry
Sources:
Amgen Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Amgen Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
8.31 %